CG Oncology, Inc. Common stockCGONNASDAQ
Loading
Revenue ScalingExpanding
Percentile Rank75
3Y CAGR+176.6%
Studio
Year-over-Year Change

Total revenue from sales of goods and services

3Y CAGR
+176.6%/yr
Annual compound
Percentile
P75
Within normal range
vs 3Y Ago
21.2x
Strong expansion
Streak
3 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$4.04M+254.7%
2024$1.14M+458.3%
2023$204000.00+6.8%
2022$191000.00-98.2%
2021$10.36M-